Filza Hussain, MD
Psychiatry · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hussain’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C149583 · Current
Licensed to practise in California · since 2017 · expires 2026-10-31 · Aga Khan University, Aga Khan Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$44,953
Medicare paid this office $44,953 for 182 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Psychiatric diagnostic evaluation with medical services | 143 | $22,420 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $15,673 | $71 |
Who their Medicare patients are
182 Original Medicare patients in 2024. Average age 69 · Under 65 28% · 85 and older 11% · Women 52% · Also on Medicaid 51% · Health risk score 3.34. Sicker patients than 9 in 10 peers; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 75% · Depression 57% · Dementia 54% · Chronic kidney disease 53% · Diabetes 47% · Coronary heart disease 44% · Heart failure 42% · Atrial fibrillation 37% · Cancer 23% · COPD 21% · Stroke 21%.
The office billed $239,527, Medicare allowed $56,402 and paid $44,953; for 428 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 182 | 428 | 69 | 3.34 | $239,527 | $44,953 |
| 2023 | 195 | 475 | 67 | 3.59 | $273,028 | $47,787 |
| 2022 | 197 | 474 | 68 | 2.68 | $280,262 | $47,699 |
| 2021 | 200 | 480 | 64 | 2.90 | $271,731 | $48,021 |
| 2020 | 172 | 415 | 66 | 3.06 | $222,462 | $38,048 |
| 2019 | 168 | 478 | 65 | 3.05 | $223,997 | $42,942 |
| 2018 | 226 | 661 | 65 | 2.69 | $249,722 | $53,952 |
| 2017 | 390 | 780 | 57 | 1.69 | $198,984 | $44,405 |
| 2016 | 374 | 1,069 | 55 | 1.42 | $292,619 | $77,623 |
| 2015 | 312 | 1,158 | 55 | 1.41 | $302,467 | $86,078 |
| 2014 | 246 | 1,041 | 56 | 1.34 | $264,874 | $78,264 |
| 2013 | 151 | 404 | 54 | 1.29 | $110,974 | $28,070 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Psychiatric diagnostic evaluation with medical services | 154 | $23,953 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $13,861 | $72 |
| Return visit (30+ min) | 12 | $1,807 | $90 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $831 | $40 |
2022: 3 services
| Psychiatric diagnostic evaluation with medical services | 164 | $26,267 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 102 | $14,258 | $65 |
| Telehealth originating site facility fee | 12 | $457 | $22 |
2021: 6 services
| Psychiatric diagnostic evaluation with medical services | 131 | $21,084 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $10,755 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $3,627 | $95 |
| Long return visit (40+ min) | 11 | $3,189 | $168 |
| Return visit (30+ min) | 12 | $1,674 | $93 |
| Telehealth originating site facility fee | 18 | $627 | $22 |
2020: 6 services
| Psychiatric diagnostic evaluation with medical services | 124 | $16,400 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $10,179 | $67 |
| Long return visit (40+ min) | 11 | $4,764 | $140 |
| Psychiatric diagnostic evaluation with medical services | 20 | $2,789 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,320 | $97 |
| Telehealth originating site facility fee | 24 | $956 | $21 |
2019: 6 services
| Psychiatric diagnostic evaluation with medical services | 126 | $16,265 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $11,969 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $5,764 | $93 |
| Long return visit (40+ min) | 14 | $3,096 | $124 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,399 | $127 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $700 | $35 |
2018: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $23,251 | $65 |
| Psychiatric diagnostic evaluation with medical services | 145 | $19,242 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $3,370 | $94 |
| Return visit (30+ min) | 15 | $1,837 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,711 | $122 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,014 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $988 | $90 |
2017: 9 services
| Return visit (30+ min) | 194 | $14,964 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $9,596 | $64 |
| Psychotherapy, 45 minutes | 22 | $6,161 | $55 |
| Short return visit (20+ min) | 86 | $3,129 | $33 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,602 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,309 | $93 |
| Long return visit (40+ min) | 12 | $1,103 | $85 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $899 | $31 |
| Short return visit | 20 | $430 | $20 |
2016: 9 services
| Return visit (30+ min) | 270 | $39,397 | $71 |
| Psychotherapy, 1 hour | 31 | $12,257 | $91 |
| Long return visit (40+ min) | 61 | $6,256 | $103 |
| Psychiatric diagnostic evaluation with medical services | 46 | $4,938 | $107 |
| Psychotherapy, 45 minutes | 24 | $4,662 | $65 |
| Short return visit (20+ min) | 65 | $3,553 | $48 |
| Family psychotherapy with patient, 50 minutes | 11 | $1,550 | $77 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $902 | $30 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $883 | $55 |
2015: 8 services
| Return visit (30+ min) | 211 | $50,368 | $73 |
| Psychotherapy, 1 hour | 24 | $14,952 | $91 |
| Psychiatric diagnostic evaluation with medical services | 60 | $5,659 | $94 |
| Long return visit (40+ min) | 33 | $3,811 | $106 |
| Short return visit (20+ min) | 48 | $3,005 | $46 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,444 | $56 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $1,406 | $30 |
| Psychiatric diagnostic evaluation | 12 | $1,177 | $98 |
2014: 7 services
| Return visit (30+ min) | 179 | $45,631 | $72 |
| Psychotherapy, 1 hour | 25 | $17,166 | $94 |
| Psychiatric diagnostic evaluation with medical services | 52 | $5,073 | $98 |
| Long return visit (40+ min) | 33 | $2,930 | $86 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $1,018 | $30 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $881 | $55 |
| Short return visit (20+ min) | 13 | $773 | $55 |
2013: 5 services
| Return visit (30+ min) | 87 | $10,286 | $65 |
| Psychotherapy, 1 hour | 16 | $5,967 | $74 |
| Long return visit (40+ min) | 52 | $4,931 | $87 |
| Psychiatric diagnostic evaluation with medical services | 25 | $2,286 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $960 | $53 |
Medicaid work
$14,452 in 2024
Medicaid paid $14,452 for 200 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Psychiatric diagnostic evaluation with medical services | 116 | $12,071 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 84 | $2,381 |
| 2024 | 200 | 2 | 26 | $14,452 |
| 2023 | 237 | 2 | 27 | $16,521 |
| 2022 | 267 | 2 | 30 | $21,648 |
| 2021 | 160 | 3 | 28 | $9,495 |
See the largest Medicaid services in earlier years
2023
| Psychiatric diagnostic evaluation with medical services | 181 | $14,519 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 56 | $2,002 |
2022
| Psychiatric diagnostic evaluation with medical services | 232 | $20,268 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 35 | $1,380 |
2021
| Psychiatric diagnostic evaluation with medical services | 70 | $6,632 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 75 | $2,480 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 15 | $383 |
Drugs they prescribed that Part D paid
$9,120
Pharmacies billed $9,120 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 258) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
251 generic and fewer than 11 brand-name prescriptions · $9,120 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Pregabalin | 19 | $427 | $22 |
| Escitalopram | 70 | $377 | $5 |
| Hydroxyzine | 18 | $366 | $20 |
| Doxepin | 11 | $228 | $21 |
| Duloxetine | 14 | $213 | $15 |
See all 8 drugs
| Pregabalin | 19 | $427 | $22 |
| Escitalopram | 70 | $377 | $5 |
| Hydroxyzine | 18 | $366 | $20 |
| Doxepin | 11 | $228 | $21 |
| Duloxetine | 14 | $213 | $15 |
| Venlafaxine Hcl Er | 12 | $89 | $7 |
| Bupropion Xl | 17 | $55 | $3 |
| Sertraline | 17 | $36 | $2 |
Year by year
| 2024 | 258 | 26 | 0% (0) | None | $9,120 |
| 2023 | 261 | 24 | 0% (0) | None | $16,643 |
| 2022 | 240 | 24 | 0% (0) | 13% | $30,367 |
| 2021 | 343 | 32 | 0% (0) | 13% | $33,021 |
| 2020 | 298 | 21 | 0% (0) | 16% | $35,774 |
| 2019 | 225 | 32 | 0% (0) | 16% | $35,204 |
| 2018 | 222 | 56 | 0% (0) | 14% | $40,091 |
| 2017 | 5,748 | 347 | 0% (0) | 6% | $298,565 |
| 2016 | 7,772 | 428 | 0% (0) | 8% | $535,781 |
| 2015 | 6,163 | 279 | None | 12% | $598,140 |
| 2014 | 5,116 | 229 | None | 13% | $550,956 |
| 2013 | 944 | 135 | 0% (0) | 15% | $90,168 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Guanfacine | 14 | $951 | $68 |
| Escitalopram | 42 | $537 | $13 |
| Venlafaxine Hcl Er | 11 | $436 | $40 |
| Hydroxyzine | 15 | $430 | $29 |
| Duloxetine | 31 | $371 | $12 |
| Sertraline | 28 | $243 | $9 |
| Trazodone | 18 | $177 | $10 |
| Doxepin | 11 | $108 | $10 |
| Lamotrigine | 11 | $91 | $8 |
| Bupropion Xl | 21 | $58 | $3 |
2022: 13 drugs
| Latuda | 11 | $17,053 | $1,550 |
| Prozac | 12 | $6,080 | $507 |
| Guanfacine | 30 | $1,141 | $38 |
| Trazodone | 17 | $221 | $13 |
| Pregabalin | 17 | $215 | $13 |
| Venlafaxine Hcl Er | 12 | $192 | $16 |
| Hydroxyzine | 11 | $158 | $14 |
| Lamotrigine | 20 | $149 | $7 |
| Escitalopram | 19 | $134 | $7 |
| Mirtazapine | 11 | $125 | $11 |
| Duloxetine | 11 | $105 | $10 |
| Sertraline | 16 | $97 | $6 |
| Clonazepam | 12 | $34 | $3 |
2021: 12 drugs
| Latuda | 13 | $17,000 | $1,308 |
| Viibryd | 21 | $6,650 | $317 |
| Mirtazapine | 25 | $731 | $29 |
| Escitalopram | 50 | $548 | $11 |
| Guanfacine | 27 | $507 | $19 |
| Hydroxyzine | 35 | $455 | $13 |
| Trazodone | 29 | $323 | $11 |
| Sertraline | 24 | $255 | $11 |
| Venlafaxine Hcl Er | 15 | $234 | $16 |
| Lamotrigine | 21 | $137 | $7 |
| Lorazepam | 14 | $55 | $4 |
| Clonazepam | 14 | $47 | $3 |
2020: 11 drugs
| Latuda | 13 | $16,205 | $1,247 |
| Viibryd | 23 | $6,448 | $280 |
| Hydroxyzine | 35 | $682 | $19 |
| Escitalopram | 47 | $415 | $9 |
| Guanfacine | 27 | $344 | $13 |
| Venlafaxine Hcl Er | 23 | $289 | $13 |
| Bupropion Hcl Sr | 20 | $185 | $9 |
| Sertraline | 11 | $149 | $14 |
| Lamotrigine | 23 | $138 | $6 |
| Trazodone | 15 | $94 | $6 |
| Clonazepam | 13 | $32 | $2 |
2019: 10 drugs
| Latuda | 12 | $14,259 | $1,188 |
| Prozac | 11 | $8,458 | $769 |
| Viibryd | 12 | $3,179 | $265 |
| Escitalopram | 54 | $491 | $9 |
| Bupropion Xl | 17 | $289 | $17 |
| Venlafaxine Hcl Er | 13 | $222 | $17 |
| Hydroxyzine | 13 | $206 | $16 |
| Lamotrigine | 24 | $143 | $6 |
| Trazodone | 14 | $105 | $8 |
| Clonazepam | 12 | $30 | $3 |
2018: 7 drugs
| Latuda | 13 | $15,817 | $1,217 |
| Bupropion Xl | 12 | $609 | $51 |
| Mirtazapine | 20 | $303 | $15 |
| Trazodone | 21 | $153 | $7 |
| Lamotrigine | 24 | $148 | $6 |
| Escitalopram | 17 | $122 | $7 |
| Clonazepam | 15 | $71 | $5 |
2017: 62 drugs
| Latuda | 31 | $35,313 | $1,139 |
| Aripiprazole | 109 | $29,518 | $271 |
| Chlorpromazine | 27 | $21,950 | $813 |
| Risperdal Consta | 16 | $20,535 | $1,283 |
| Divalproex Sodium Er | 90 | $11,708 | $130 |
| Bupropion Xl | 215 | $9,323 | $43 |
| Clozapine | 74 | $9,249 | $125 |
| Pristiq | 24 | $8,948 | $373 |
| Quetiapine | 377 | $7,552 | $20 |
| Duloxetine | 119 | $7,221 | $61 |
| Perphenazine | 46 | $6,022 | $131 |
| Risperidone | 310 | $5,791 | $19 |
| Viibryd | 19 | $5,394 | $284 |
| Fluphenazine | 34 | $5,262 | $155 |
| Venlafaxine Hcl Er | 163 | $4,791 | $29 |
| Dextroamphetamine-Amphet Er | 20 | $3,770 | $189 |
| Trazodone | 373 | $3,166 | $8 |
| Divalproex | 98 | $3,026 | $31 |
| Olanzapine | 112 | $3,002 | $27 |
| Haloperidol | 79 | $2,955 | $37 |
| Carbamazepine | 27 | $2,865 | $106 |
| Benztropine Mesylate | 219 | $2,754 | $13 |
| Fluoxetine | 218 | $2,595 | $12 |
| Prazosin | 59 | $2,320 | $39 |
| Amitriptyline | 67 | $2,311 | $34 |
| Clonazepam | 363 | $2,134 | $6 |
| Methylphenidate | 32 | $2,060 | $64 |
| Tranylcypromine Sulfate | 14 | $1,946 | $139 |
| Sertraline | 247 | $1,892 | $8 |
| Lamotrigine | 212 | $1,714 | $8 |
| Lorazepam | 242 | $1,655 | $7 |
| Buspirone | 103 | $1,565 | $15 |
| Ziprasidone | 33 | $1,521 | $46 |
| Valproic Acid | 13 | $1,515 | $117 |
| Alprazolam | 203 | $1,453 | $7 |
| Escitalopram | 151 | $1,451 | $10 |
| Mirtazapine | 79 | $1,424 | $18 |
| Gabapentin | 78 | $1,349 | $17 |
| Bupropion Hcl Sr | 45 | $1,337 | $30 |
| Desvenlafaxine Succinate Er | 16 | $1,195 | $75 |
| Haloperidol Decanoate | 13 | $1,139 | $88 |
| Fluvoxamine Maleate | 36 | $1,038 | $29 |
| Propranolol | 31 | $959 | $31 |
| Hydroxyzine Pamoate | 29 | $787 | $27 |
| Citalopram Hbr | 159 | $728 | $5 |
| Topiramate | 74 | $674 | $9 |
| Paroxetine | 67 | $646 | $10 |
| Oxcarbazepine | 20 | $569 | $28 |
| Trihexyphenidyl | 30 | $473 | $16 |
| Amantadine | 14 | $468 | $33 |
| Lithium Carbonate | 62 | $416 | $7 |
| Lithium Carbonate Er | 24 | $409 | $17 |
| Bupropion | 14 | $408 | $29 |
| Zolpidem | 72 | $370 | $5 |
| Hydroxyzine | 20 | $361 | $18 |
| Doxepin | 19 | $329 | $17 |
| Clonidine | 40 | $296 | $7 |
| Venlafaxine | 11 | $248 | $23 |
| Guanfacine | 15 | $219 | $15 |
| Diazepam | 46 | $204 | $4 |
| Temazepam | 22 | $185 | $8 |
| Donepezil | 23 | $154 | $7 |
2016: 71 drugs
| Risperdal Consta | 84 | $86,763 | $1,033 |
| Latuda | 54 | $55,717 | $1,032 |
| Aripiprazole | 137 | $37,428 | $273 |
| Clozapine | 250 | $30,699 | $123 |
| Invega | 21 | $28,856 | $1,374 |
| Chlorpromazine | 26 | $22,986 | $884 |
| Invega Sustenna | 15 | $16,717 | $1,114 |
| Divalproex Sodium Er | 109 | $15,273 | $140 |
| Pristiq | 47 | $14,259 | $303 |
| Bupropion Xl | 308 | $13,301 | $43 |
| Duloxetine | 194 | $11,771 | $61 |
| Quetiapine | 439 | $9,779 | $22 |
| Viibryd | 39 | $7,876 | $202 |
| Dextroamphetamine-Amphet Er | 37 | $7,600 | $205 |
| Venlafaxine Hcl Er | 199 | $5,601 | $28 |
| Risperidone | 352 | $5,258 | $15 |
| Perphenazine | 34 | $5,201 | $153 |
| Fluphenazine | 68 | $4,966 | $73 |
| Fluoxetine | 288 | $4,658 | $16 |
| Clonazepam | 506 | $4,071 | $8 |
| Benztropine Mesylate | 308 | $3,647 | $12 |
| Trazodone | 434 | $3,494 | $8 |
| Tranylcypromine Sulfate | 16 | $3,390 | $212 |
| Ziprasidone | 66 | $3,252 | $49 |
| Lamotrigine Er | 12 | $3,245 | $270 |
| Gabapentin | 164 | $3,229 | $20 |
| Methylphenidate | 41 | $3,169 | $77 |
| Carbamazepine | 39 | $3,097 | $79 |
| Haloperidol | 79 | $2,985 | $38 |
| Amitriptyline | 120 | $2,909 | $24 |
| Olanzapine | 123 | $2,720 | $22 |
| Thiothixene | 23 | $2,613 | $114 |
| Sertraline | 380 | $2,513 | $7 |
| Lamotrigine | 301 | $2,327 | $8 |
| Divalproex | 93 | $2,251 | $24 |
| Prazosin | 66 | $2,036 | $31 |
| Mirtazapine | 153 | $2,026 | $13 |
| Escitalopram | 124 | $1,961 | $16 |
| Alprazolam | 274 | $1,819 | $7 |
| Depakote Er | 12 | $1,801 | $150 |
| Haloperidol Decanoate | 34 | $1,733 | $51 |
| Modafinil | 12 | $1,678 | $140 |
| Lorazepam | 352 | $1,651 | $5 |
| Fluvoxamine Maleate | 25 | $1,465 | $59 |
| Bupropion Hcl Sr | 61 | $1,425 | $23 |
| Buspirone | 125 | $1,314 | $11 |
| Paroxetine | 110 | $1,264 | $11 |
| Carbamazepine Er | 12 | $1,259 | $105 |
| Zolpidem Tartrate Er | 18 | $1,174 | $65 |
| Hydroxyzine Pamoate | 44 | $1,130 | $26 |
| Valproic Acid | 11 | $1,126 | $102 |
| Hydroxyzine | 29 | $1,052 | $36 |
| Zolpidem | 106 | $993 | $9 |
| Citalopram Hbr | 143 | $815 | $6 |
| Amantadine | 12 | $782 | $65 |
| Doxepin | 33 | $704 | $21 |
| Propranolol | 28 | $701 | $25 |
| Topiramate | 58 | $561 | $10 |
| Digoxin | 22 | $549 | $25 |
| Lithium Carbonate | 63 | $427 | $7 |
| Temazepam | 75 | $367 | $5 |
| Dextroamphetamine-Amphetamine | 16 | $329 | $21 |
| Trihexyphenidyl | 24 | $289 | $12 |
| Guanfacine | 21 | $275 | $13 |
| Lithium Carbonate Er | 18 | $257 | $14 |
| Oxcarbazepine | 15 | $218 | $15 |
| Clonidine | 35 | $199 | $6 |
| Eszopiclone | 12 | $192 | $16 |
| Diazepam | 44 | $166 | $4 |
| Nortriptyline | 13 | $151 | $12 |
| Donepezil | 20 | $93 | $5 |
2015: 67 drugs
| Abilify | 88 | $84,459 | $960 |
| Risperdal Consta | 79 | $68,864 | $872 |
| Latuda | 60 | $64,052 | $1,068 |
| Invega Sustenna | 24 | $34,438 | $1,435 |
| Invega | 30 | $34,312 | $1,144 |
| Clozapine | 242 | $30,664 | $127 |
| Aripiprazole | 46 | $27,915 | $607 |
| Divalproex Sodium Er | 109 | $22,194 | $204 |
| Duloxetine | 128 | $14,078 | $110 |
| Bupropion Xl | 262 | $13,520 | $52 |
| Chlorpromazine | 11 | $9,392 | $854 |
| Seroquel Xr | 16 | $7,195 | $450 |
| Ziprasidone | 68 | $6,115 | $90 |
| Adderall | 14 | $5,787 | $413 |
| Dextroamphetamine-Amphet Er | 32 | $5,706 | $178 |
| Quetiapine | 272 | $5,279 | $19 |
| Seroquel | 11 | $4,655 | $423 |
| Perphenazine | 24 | $4,527 | $189 |
| Venlafaxine Hcl Er | 155 | $4,491 | $29 |
| Gabapentin | 127 | $4,212 | $33 |
| Risperidone | 221 | $3,784 | $17 |
| Viibryd | 25 | $3,687 | $147 |
| Methylphenidate | 41 | $3,634 | $89 |
| Tranylcypromine Sulfate | 11 | $3,300 | $300 |
| Sertraline | 407 | $3,257 | $8 |
| Fluoxetine | 203 | $3,007 | $15 |
| Amitriptyline | 84 | $2,697 | $32 |
| Vyvanse | 12 | $2,697 | $225 |
| Alprazolam | 182 | $2,666 | $15 |
| Benztropine Mesylate | 223 | $2,571 | $12 |
| Clonazepam | 475 | $2,546 | $5 |
| Carbamazepine | 18 | $2,401 | $133 |
| Lamotrigine | 268 | $2,142 | $8 |
| Trazodone | 341 | $2,138 | $6 |
| Hydroxyzine | 44 | $2,041 | $46 |
| Thiothixene | 25 | $2,021 | $81 |
| Dextroamphetamine-Amphetamine | 42 | $1,943 | $46 |
| Bupropion Hcl Sr | 85 | $1,913 | $23 |
| Olanzapine | 121 | $1,812 | $15 |
| Zolpidem Tartrate Er | 22 | $1,734 | $79 |
| Mirtazapine | 120 | $1,728 | $14 |
| Depakote Er | 12 | $1,703 | $142 |
| Fluvoxamine Maleate | 27 | $1,634 | $61 |
| Haloperidol | 60 | $1,522 | $25 |
| Lorazepam | 228 | $1,501 | $7 |
| Prazosin | 32 | $1,424 | $44 |
| Bupropion | 27 | $1,328 | $49 |
| Disulfiram | 14 | $1,073 | $77 |
| Hydroxyzine Pamoate | 46 | $996 | $22 |
| Zaleplon | 28 | $891 | $32 |
| Divalproex | 23 | $772 | $34 |
| Fluphenazine | 32 | $743 | $23 |
| Buspirone | 79 | $728 | $9 |
| Topiramate | 52 | $711 | $14 |
| Doxepin | 38 | $689 | $18 |
| Haloperidol Decanoate | 15 | $684 | $46 |
| Zolpidem | 90 | $606 | $7 |
| Paroxetine | 53 | $573 | $11 |
| Citalopram Hbr | 138 | $471 | $3 |
| Lithium Carbonate | 41 | $343 | $8 |
| Escitalopram | 29 | $267 | $9 |
| Donepezil | 18 | $183 | $10 |
| Temazepam | 41 | $166 | $4 |
| Propranolol | 19 | $150 | $8 |
| Nortriptyline | 13 | $141 | $11 |
| Diazepam | 26 | $83 | $3 |
| Trihexyphenidyl | 12 | $76 | $6 |
2014: 63 drugs
| Risperdal Consta | 76 | $81,881 | $1,077 |
| Abilify | 88 | $79,819 | $907 |
| Invega | 34 | $37,512 | $1,103 |
| Invega Sustenna | 31 | $36,618 | $1,181 |
| Clozapine | 279 | $34,395 | $123 |
| Latuda | 42 | $34,181 | $814 |
| Quetiapine | 243 | $25,388 | $104 |
| Duloxetine | 82 | $22,708 | $277 |
| Divalproex Sodium Er | 100 | $22,055 | $221 |
| Ziprasidone | 66 | $14,848 | $225 |
| Olanzapine | 79 | $13,405 | $170 |
| Bupropion Xl | 202 | $11,138 | $55 |
| Seroquel | 12 | $8,107 | $676 |
| Venlafaxine Hcl Er | 118 | $5,371 | $46 |
| Adderall | 16 | $5,307 | $332 |
| Depakote Er | 21 | $5,024 | $239 |
| Perphenazine | 24 | $4,820 | $201 |
| Fluoxetine | 188 | $4,241 | $23 |
| Sertraline | 381 | $4,141 | $11 |
| Methylphenidate | 26 | $3,389 | $130 |
| Amphetamine Salt Combo | 46 | $3,244 | $71 |
| Clonazepam | 463 | $3,015 | $7 |
| Lamotrigine | 194 | $2,679 | $14 |
| Olanzapine Odt | 13 | $2,406 | $185 |
| Gabapentin | 59 | $2,251 | $38 |
| Dextroamphetamine-Amphet Er | 16 | $2,217 | $139 |
| Bupropion | 55 | $2,133 | $39 |
| Risperidone | 145 | $2,031 | $14 |
| Trazodone | 309 | $1,928 | $6 |
| Fluvoxamine Maleate | 21 | $1,911 | $91 |
| Amitriptyline | 93 | $1,895 | $20 |
| Bupropion Hcl Sr | 60 | $1,676 | $28 |
| Mirtazapine | 98 | $1,559 | $16 |
| Hydroxyzine | 40 | $1,530 | $38 |
| Benztropine Mesylate | 157 | $1,500 | $10 |
| Lorazepam | 189 | $1,345 | $7 |
| Hydroxyzine Pamoate | 35 | $1,113 | $32 |
| Viibryd | 12 | $1,075 | $90 |
| Topiramate | 29 | $964 | $33 |
| Paroxetine | 47 | $909 | $19 |
| Thiothixene | 23 | $904 | $39 |
| Haloperidol Decanoate | 18 | $810 | $45 |
| Fluphenazine | 50 | $777 | $16 |
| Carbamazepine | 21 | $774 | $37 |
| Divalproex | 31 | $728 | $23 |
| Buspirone | 30 | $691 | $23 |
| Alprazolam | 105 | $679 | $6 |
| Prazosin | 18 | $658 | $37 |
| Naltrexone | 13 | $628 | $48 |
| Citalopram Hbr | 127 | $580 | $5 |
| Haloperidol | 27 | $547 | $20 |
| Zolpidem | 68 | $539 | $8 |
| Venlafaxine | 11 | $529 | $48 |
| Doxepin | 27 | $505 | $19 |
| Escitalopram | 24 | $476 | $20 |
| Thioridazine | 13 | $426 | $33 |
| Lithium Carbonate | 25 | $333 | $13 |
| Donepezil | 19 | $296 | $16 |
| Temazepam | 39 | $190 | $5 |
| Diazepam | 34 | $186 | $5 |
| Nortriptyline | 12 | $166 | $14 |
| Trihexyphenidyl | 12 | $88 | $7 |
| Propranolol | 15 | $84 | $6 |
2013: 25 drugs
| Risperdal Consta | 13 | $12,381 | $952 |
| Latuda | 12 | $9,626 | $802 |
| Olanzapine | 18 | $6,521 | $362 |
| Quetiapine | 58 | $5,884 | $101 |
| Ziprasidone | 20 | $5,213 | $261 |
| Clozapine | 45 | $5,120 | $114 |
| Divalproex Sodium Er | 11 | $2,172 | $197 |
| Bupropion Xl | 36 | $2,026 | $56 |
| Sertraline | 79 | $1,261 | $16 |
| Venlafaxine Hcl Er | 31 | $1,243 | $40 |
| Amphetamine Salt Combo | 12 | $860 | $72 |
| Lamotrigine | 38 | $854 | $22 |
| Fluoxetine | 28 | $817 | $29 |
| Risperidone | 27 | $722 | $27 |
| Clonazepam | 93 | $690 | $7 |
| Bupropion | 13 | $439 | $34 |
| Trazodone | 57 | $375 | $7 |
| Lorazepam | 42 | $369 | $9 |
| Mirtazapine | 23 | $366 | $16 |
| Fluphenazine | 11 | $310 | $28 |
| Divalproex | 11 | $247 | $22 |
| Benztropine Mesylate | 25 | $230 | $9 |
| Citalopram Hbr | 23 | $147 | $6 |
| Alprazolam | 22 | $125 | $6 |
| Zolpidem | 21 | $119 | $6 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1629260898
- Licence
- CA C149583, MN 51947, WI 60969-20California C149583: Current · expires 2026-10-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- MN ENROLLED
- Taxonomy
- Federal specialty code 2084P0015X (2084P0015X); Neurology (2084N0400X); Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2007-08-13
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.